Clinical Trials Browser

Phase 1/2 × Pancreatic Cancer Metastatic × Clear all

NCT07342725 2026-01-15

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

NCT07040228 2025-06-27

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

NCT06888648 2025-03-21

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Metastatic